chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tingling sensation on the arm where injection was given; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PARAESTHESIA (Tingling sensation on the arm where injection was given) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PARAESTHESIA (Tingling sensation on the arm where injection was given). At the time of the report, INJECTION SITE PARAESTHESIA (Tingling sensation on the arm where injection was given) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported. No Treatment information was reported.
shingles after receiving the Moderna COVID-19 vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles after receiving the Moderna COVID-19 vaccine.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: SHINGRIX (received the shingles vaccine in October 2018 and in March 2019, but in spite of that and they experienced shingles after receiving the Moderna COVID-19 vaccine).    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced HERPES ZOSTER (shingles after receiving the Moderna COVID-19 vaccine.). At the time of the report, HERPES ZOSTER (shingles after receiving the Moderna COVID-19 vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided by reporter. No treatment information was provided.
on 1st day, arm started feeling heavy;by 2nd day pain in arm was excruciating;moved up & down arm & was unable to sleep @ noc for a couple of months;arms would get stiff & lock up @ noc;mostly gets sore when weather moist;not full ROM;
I came back from my cruise I had a sore throat, was a little dizzy, had a mild headache, a little tired, sneezing, disoriented, no fever, slight congestion. I thought I had jet lag from my vacation. I took a home COVID 19 test on June 16, 2022 it was very light pink so I thought I got a false positive. I took a second test on the morning of June 17, 2022 and this test came back dark pink and positive very fast. They did prescribe me PAXLOVID but unfortunately I did not receive the call to pick it up it the time frame to take it. I am feelin better, I can breathe better but I do not feel one hundred percent myself yet.
pt recv vax & reported pressure sensation to substernal area;c/o diff breathing;BP 124/90;radial pulse 60 strong, regular;c/o tingling & numbness to fingertips;
Pertussis-related encephalopathy hospitalized @ medical ctr. Evidence for GBS-like illness--presented w/acute flaccid paralysis w/encephalopathic features.Loss of deep tendon reflexes-became areflexic
Light headed, dizzy; Sick feeling; This is a spontaneous report from a non-contactable pharmacist. A 67-year-old male patient received the BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot Number: EW0151) via an intramuscular route of administration in the left arm on 06May2021 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. On 06May2021, the patient felt light headed, dizzy and sick feeling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, it was unknown whether the patient had not been tested for COVID-19. The clinical outcome of the events light headed, dizzy and sick feeling was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
4 days following vaccination, I awoke with severe pain, swelling, and immobility in my right ankle.  No prior trauma or injury.  X-rays and MRI showed no injury.  Severe bruising in the ankle developed over the next week with nerve pain attacks at night.  Over the next two months, I began having pain in both ankles and neuropathy in both feet and arms.  Have since had full exams by an orthopedist and rheumatologist, but neither can find an underlying cause.  All rheumatology related blood work returned normal, but for presence of HLA-B27 marker.  Neuropathy continues.  Recent occurence of episcleritis in left eye.  Awaiting neurology consult as next step.
Mom reports red hard bump at injection site accompanied with small red bumps/rash around the site.
Muscle weakness, stiff arm, site reaction     MRSA Staph which 10/22/07-records received for DOS-08/04/05-discussion about allergy to thimersol. Td not given. menactra waiver received after vaccine given. krk 11/6/07-office notes for DOS 7/23/07-returns with complaints of recurring skin infection. Mainly on arm, quite tender. He has not started back on medications for this. No fever or chills or sweats. Left upper arm abscess. Impression:recurrent skin abscesses, most likely secondary to methicillin-resistant staphylococcus aureus.  11/7/07-additional notes for DOS 5/26/05-8/2/07-C/O sore throat and fatigue, pharyngitis. Staph infection under arm has had since 11/06, PE erythema with central pustles to left upper arm. DX staph infection Follow-up: MRSA Staph infections numerous time, folliculitis, skin allergies.
delayed reaction: vaccine @ 9am and got extreme hives 4:30pm with itchy arms elbow to wrist used benadryl po  with ice sought attention at walk in clinic-they sent him to ER ER gave patient epi pen and antihistamine prescription (did not administer) doing ok now
Information has been received from a health professional concerning a 12 month old female who on 12 Jun 2006 was vaccinated with a first 0.5 ml subcutaneous dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+0 varicella virus vaccine live (lot#65268c/113R).  On 12 Jun 2006 the patient developed and immediate injection site reaction, with a  2 cm rash with induration and extended redness about 1/2 inch below the injection site.  There were no other symptoms noted.  The reaction was described as "looking like a bug bite".  Unspecified attention was sought.  No product quality complaint was involved.  No other information was provided.  Additional information has been requested.
Pt tested positive for COVID 10/11/2021.  Developed progressive dyspnea and was admitted to the hospital 10/26 Previously hospitalized and reported e-report # 678590
Broke out with small raised bumps some with little blisters (approx. 50-75 places), itches, no fever.
Violent shaking of body for 2-3 hours, legs didn't feel like my own, aching muscles, constant need to urinate, back ache, unable to warm myself. Next day severe headache, severe muscle aches, malaise, no desire to eat, hurt to move head/neck.
Could not eat; Needed to eat bland foods; Stomach feels wonky; Body aches; Threw up; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Could not eat), APPETITE DISORDER (Needed to eat bland foods), ABDOMINAL DISCOMFORT (Stomach feels wonky), PAIN (Body aches) and VOMITING (Threw up) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history was not reported .    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (Could not eat), APPETITE DISORDER (Needed to eat bland foods), ABDOMINAL DISCOMFORT (Stomach feels wonky), PAIN (Body aches), VOMITING (Threw up) and HEADACHE (Headaches). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (Could not eat), APPETITE DISORDER (Needed to eat bland foods), ABDOMINAL DISCOMFORT (Stomach feels wonky), PAIN (Body aches), VOMITING (Threw up) and HEADACHE (Headaches) outcome was unknown.            No Concomitant medications were provided
the patient was administered an improperly stored dose of VAQTA; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant medications were provided. On 22-MAY-2020, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) (lot # S020241 and expiration date 23-AUG-2020; dose and route of administration were not reported). The vaccine underwent a temperature excursion with a temperature of 12.1 Celsius degrees for a time frame of 16 hours and 11 minutes. There was no previous temperature excursion. The call was because of a data logger. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S020241; expirationdate: 23-AUG-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Rash and hives on upper body; Rash and hives on upper body; This is a spontaneous report from a contactable consumer (patient). A 78-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9264), via an unspecified route of administration, administered in left arm on 03Feb2021 13:00 (age at vaccination: 78 years) as 1st dose, single for covid-19 immunisation. The patient was vaccinated in clinic The patient medical history included vascular dementia. The patient had allergies to medicines include Neosporin. Concomitant medications included citalopram; donepezil hydrochloride (DONPEZIL) 5mg and atorvastatin 40mg. The patient did not receive any other vaccine in four weeks. On 03Feb2021 13:00, the patient experienced rash and hives on upper body. The patient received Benadryl as treatment for the adverse events. The patient did not get covid prior to vaccination and was not tested post vaccination. The outcome of the events was reported to be recovering.  Information on the Lot/Batch number has been requested.  Follow-up attempts completed. No further information expected.
Trouble walking, numbness and tingling in hands, neck pain, trouble sitting up, general discomfort then inability to walk. Dx: Guillain-Barre. Transferred to other hospital for plasmapheresis treatment.
CONGESTION, FATIGUE, HEADACHE, DIARRHEA; duration lasting 18 hrs; TYLENOL 1000MG ONE TIME DOSE, SUMATRIPTAN, Flonase nasal spray one time dose; effective
feeling very drunk; intense euphoria; slurred speech; fits of giggling; unable to drive; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 37 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Oct2021 07:30 (Lot number: FF8841) at the age of 37 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLUOXETINE; NORETHINDRONE [NORETHISTERONE]; FLEXERIL [CEFIXIME]. Past drug history included: Amoxicillin, reaction(s): "Known allergies: amoxicillin"; Codeine, reaction(s): "Known allergies: codeine". Vaccination history included: Bnt162b2 (Previous dose product: Covid-19, Previous dose brand: Pfizer, Previous dose Lot number: EN6198, Previous dose Administration date= 01Mar2021, Previous Dose number=1, Previous dose Vaccine location= Left arm), administration date: 01Mar2021, when the patient was 37 years old, for Covid-19 immunization; Bnt162b2 (Previous dose product: Covid-19, Previous dose brand: Pfizer, Previous dose Lot number: ER2613, Previous dose Administration date= 22Mar2021, Previous Dose number=2, Previous dose Vaccine location= Left arm), administration date: 22Mar2021, when the patient was 37 years old, for Covid-19 immunization; Influenza vaccine (Other vaccine 4 weeks product: Influenza Vaccine, Other vaccine 4 weeks vaccine date: 22Sep2021, Other vaccine 4 weeks vaccine location: Left arm), administration date: 22Sep2021, when the patient was 37 years old.  The following information was reported: FEELING DRUNK (non-serious) with onset 06Oct2021 15:45, outcome "recovering", described as "feeling very drunk"; EUPHORIC MOOD (non-serious) with onset 06Oct2021 15:45, outcome "recovering", described as "intense euphoria"; DYSARTHRIA (non-serious) with onset 06Oct2021 15:45, outcome "recovering", described as "slurred speech"; INAPPROPRIATE AFFECT (non-serious) with onset 06Oct2021 15:45, outcome "recovering", described as "fits of giggling"; IMPAIRED DRIVING ABILITY (non-serious) with onset 06Oct2021 15:45, outcome "recovering", described as "unable to drive". Therapeutic measures were not taken as a result of feeling drunk, euphoric mood, dysarthria, inappropriate affect, impaired driving ability. It was reported that prior and post to vaccination the patient was not affected with Covid 19.  No follow-up attempts are possible. No further information is expected.
Immunized 6/28/03 3 PM. Reported mild headache, body aches. 6/29/03 day, worse by evening with "pounding headache, severe sore throat, body aches. To ER at 9 PM, WBC elevated, throat culture done, rapid strep negative. Given axomicillin. 6/30/03 called pt, sore throat continues "severe", some body aches. 7/1/03 - generalized symptoms gone. Sore throat somewhat improved.
19 y.o. man with with chest pain, diffuse ST elevations, and elevated troponin likely due to myopericarditis.  Most likely cause is recent administration of 2nd dose of Pfizer COVID vaccine.  ST changes non dynamic.  Chest pain controlled shortly after admission.  Echocardiogram demonstrated normal systolic function with no wall motion abnormalities.  Treating with high-dose NSAIDs and colchicine.  Neither Coronary CTA nor cardiac MR not available on the weekend thus will arrange for cardiac MR to be done week of 10/25/2021. Largely asymptomatic with downtrending troponin, minimal chest pain after onset (resolution in a few hours)
This spontaneous report as received from a pharmacy student refers to a patient of unknown age with allergy to pork who on an unknown date, was vaccinated with a dose of ZOSTAVAX. It was reported that on an unknown date, the patient had an anaphylactic reaction to ZOSTAVAX. At the time of the report, the patient's outcome was unknown. The relatedness for anaphylactic reaction and ZOSTAVAX was unknown. Additional information has been requested.
Heart palpitations. Left arm numb where received vaccine numb and still is over 2 weeks later. Left forearm and finger pain.  Insomnia for two weeks and still have it.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On 20-MAY-2016, the patient was vaccinated with improperly stored M-M-R II (lot # L003855 and expiration date 05-FEB-2017; lot # L026553 and expiration date 16-JUL-2017, albumin status therapy type, dose and route of administration were not reported) and VAQTA (lot # M011116 and expiration date 17-JUN-2017; lot # K008333 and expiration date 10-MAR-2017, dose and route of administration were not reported). The maximum temperature of excursion was 22.7 Celsius degrees with the time frame of 3 hours and 48 minutes. The minimum temperature of excursion was 0.2 Celsius degrees with the time frame of 31 hours and 1 minute. There were no known adverse effects. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
Top of the right hand swelled, severe pain top of hand, small hard bumps on chest and back.
After receiving the 2nd dose my I have had pain in my shoulder and arm. I also have tingling shooting down my arm to my hand.
In the evening after getting the vaccine, around 5 hours after the injection, I had severe nausea, vomiting, fever, intense chills and fatigue. In the following week I experienced pain around the injection site and fatigue along with issues with my menstrual cycle. Since getting the vaccine, I've had issues with cramps and spotting including today.
headaches; a little bit of fever; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 12Apr2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported.  She received first dose yesterday 12Apr2021, and today (13Apr2021), she was experiencing headache and a little bit of fever, not so much fever, but headache. Outcome of the event was unknown.  No follow-up attempts are Possible; information about lot/batch number cannot be obtained.
Localized swelling, irritation. Syncopal episode, joint pain, fever. Developed 1-2 days after immunization. Improved within 3 days and symptomatic treatment.
Approx. 1 month after the 3rd shot, he experienced numbness in his calves. The numbness is accompanied by tingling and occurs with prolonged sitting and driving. The numbness and tingling extends distally to the toes but does not radiate above the knee. The symptoms are relieved with movement for a few minutes. These symptoms persist today. During this time his lab work showed a CBC with a slightly low HCT, but normal indices. No anemia studies were performed and he was not put on iron replacement therapy. He also had increased pain in his left knee. He was evaluated locally and told his symptoms were the result of normal wear and tear. He states that the joint pain is manageable but annoying. He currently takes Glucosamine Chondroitin once a day, which he states helps his joint pain but does not fully resolve it. In 8/01, he began experiencing left-sided abdominal pain and an increased number of loose stools. He attributes these symptoms to starting after swallowing contrast for a radiologic study on 7/30/01. These symptoms have persisted and increased in severity. Currently he is experiencing constant left-sided abdominal pain as well as loose stools following every meal. He tried over the counter remedies, such as Imodium, with only minimal and temporary relief. He also tried over the counter fiber tablets, which he states made the pain worse. He has noticed some weight loss during this time. In 9/01, he began experiencing increased episodes of dizziness and light-headedness. He denies any ringing in his ears. This dizziness has impacted his balance; however, he has not had any episodes of falling. He has not experienced headache with the episodes of dizziness. At this time he has not yet been evaluated for the dizziness. He was referred to oncology for evaluation. It was determined he did not have cancer; however, the oncology service will continue to monitor him for any changes. He has vertigo without tinnitus.
Received fluzone vaccine on 10/11/07 to left arm.  On 10/12/07 mid morning, felt nausea and started to vomit.  Also had trembling to right arm.  Seen in ER on 10/12/07 and admitted for 3 days.  10/23/07Hospital medical records reviewed which reveal patient experienced wheezing, fever, chills, flu-like symptoms, cough, HA, SOB & chest pain day following her first ever flu vaccine.  Admitted 10/12-10/14/2007.  Improved & d/c to home on oral antibiotics, oral steroids, benadryl & prilosec. FINAL DX: SOB/chest pain, improved; negative cardiac enzymes; allergic reaction to flu shot, stable; wheezing, improved; diabetes mellitus, stable; HTN; stable.
About 15-30 mins after the first vaccine, my arm started hurting and pulsing, beating with heart. That lasted for maybe a week. Then I was late with my period after the 1st dose for like a week. I also had some lymph nodes and arm was sore.
pt recv vax & 1hr p/vax c/o h/a, dizziness, lower back pain, itching rt arm, & numbness of rt fingers incident happened 13MAR98;
Very sore throat on right side, felt as if gland was swollen and/or Eustachian tube was swollen beginning March 14. Hives beginning March 17 to March 30.   Hives spread to arms and legs and some on face and chest. Occasional blister like bumps and sticking sensation. Hives could be calmed with antihistamine.  Beginning March 31, hives were intermittent for a week.  Primary care physician contacted on April 9 who advised me to not get the second shot on April 10.
Swelling, itching, pain, swollen glands, infection. Doctor started antibiotic.
pain/soreness at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not applicable for this report. The reporter reported multiple patients of unknown ages and gender who had received the Shingrix vaccine and had experienced pain and soreness at the injection site. The healthcare professional did not have a specific patient, he was mentioning in general how patients experienced pain and soreness at the injection site. The reporter consent to follow up.
About 10 minutes after vaccine a red injection site appeared and then also was red further up around the shoulder (noticed because shoulder was itchy).  I also felt warm.  I have been diagnosed in the past with exercise induced asthma.  Asthma started to flare up shortly after but did not require intervention.  Was monitored by a doctor at facility where vaccine was given and symptoms did not worsen.  No medication required.  I noticed unusual muscle aches starting the next morning and persisted for a week after vaccine.  Left arm where vaccine was given did not hurt, but other right arm, shoulders and thighs were aching.  Hands seemed arthritic with movement at work.  Feet occasionally felt tingly when walking for 5 days after vaccine.  Asthma flare-ups continued after vaccine.  Had to stop and rest after climbing stairs which is  unusual for me.  The worst asthma flare-ups persisted for up to 5 days.  After 10 days at time of reporting adverse effects, asthma is still triggered but to a lesser extent.  Can climb stairs without pause now.  Airways have not fully recovered yet and I have a residual cough.  Started self treating with albuterol rescue inhaler if needed.
Patient was admitted for COVID-19 symptoms on 7/18/2022- 7/20/2022.  Medications given included ascorbic acid 1000mg PO daily, cholecalciferol 25mcg PO daily, zinc sulfate 50mg  PO daily,
Myalgia, Arthralgia, Fever, CoughWheeze, Diarrhea NauseaVomiting, CHILLS